Legend Biotech Corporation (LEGN)
NASDAQ
$18.97−$0.0900 (−0.47%) on the dayAs of the close; data may be delayed.
LEGN price, last 12 months
Key stats
- Previous close
- $19.06
- Open
- $19.12
- Day range
- $18.85 – $19.69
- 52-week range
- $16.24 – $37.50
- Volume
- 1.2M
- Avg volume (20 days)
- 2.2M
- Market cap
- $3.7B
Performance
1W+7.7%
1M−8.3%
3M−33.9%
6M+8.5%
YTD−12.7%
1Y−42.3%
vs S&P 500, 1Y−59.1 pts
Technicals and fundamentals
About Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
- Listed on
- NASDAQ
- Market cap
- $3.7B